Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

NCT: NCT07456865 · RECRUITING

NCT IDNCT07456865
StatusRECRUITING
Start Date2026-03-17
Completion2032-11

Brief Summary

The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI

Frequently Asked Questions

What is Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device?

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device is a clinical trial registered under NCT07456865. Current status: RECRUITING.

What is the status of NCT07456865?

The current status of NCT07456865 (Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device) is: RECRUITING.

When did Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device start?

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device started on 2026-03-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.